Perfusion imaging and recurrent cerebrovascular events in intracranial atherosclerotic disease or carotid occlusion

Background Large vessel disease stroke subtype carries the highest risk of early recurrent stroke. In this study we aim to look at the association between impaired perfusion and early stroke recurrence in patients with intracranial atherosclerotic disease or total cervical carotid occlusion. Methods This is a retrospective study from a comprehensive stroke center where we included consecutive patients 18 years or older with intracranial atherosclerotic disease or total cervical carotid occlusion admitted with a diagnosis of ischemic stroke within 24 h from symptom onset with National Institute Health Stroke Scale < 15, between 1 December 2016 and 30 June 2017. Patients with (1) evidence of ≥ 50% stenosis of a large intracranial artery or total carotid artery occlusion, (2) symptoms referable to the territory of the affected artery, and (3) perfusion imaging data using the RAPID processing software were included. The primary predictor was unfavorable perfusion imaging defined as Tmax > 6 s mismatch volume (penumbra volume–infarct volume) of 15 ml or more. The outcome was recurrent cerebrovascular events at 90 days defined as worsening or new neurological symptoms in the absence of a nonvascular cause attributable to the decline, or new infarct or infarct extension in the territory of the affected artery. We used Cox proportional hazards models to determine the association between impaired perfusion and recurrent cerebrovascular events. Results Sixty-two patients met our inclusion criteria; mean age 66.4 ± 13.1 years, 64.5% male (40/62) and 50.0% (31/62) with intracranial atherosclerotic disease. When compared to patients with favorable perfusion pattern, patients with unfavorable perfusion pattern were more likely to have recurrent cerebrovascular events (55.6% (10/18) versus 9.1% (4/44), p < 0.001). This association persisted after adjusting for potential confounders (adjusted hazard ratio 10.44, 95% confidence interval 2.30–47.42, p = 0.002). Conclusion Perfusion mismatch predicts recurrent cerebrovascular events in patients with ischemic stroke due to intracranial atherosclerotic disease or total cervical carotid occlusion. Studies are needed to determine the utility of revascularization strategies in this patient population.

[1]  S. Ansari,et al.  Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting , 2017, Stroke.

[2]  M. Chimowitz,et al.  Stroke Caused by Atherosclerosis of the Major Intracranial Arteries , 2017, Circulation research.

[3]  Vertebrobasilar atherosclerotic disease: is it time to revisit angioplasty? , 2016, Journal of NeuroInterventional Surgery.

[4]  Sara K. Rostanski,et al.  Imaging Parameters and Recurrent Cerebrovascular Events in Patients With Minor Stroke or Transient Ischemic Attack. , 2016, JAMA neurology.

[5]  K. Thulborn,et al.  Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease. , 2016, JAMA neurology.

[6]  J. Carroll,et al.  Letter by Saver et al regarding article, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". , 2015, Stroke.

[7]  H. Kirshner,et al.  Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. , 2015, JAMA.

[8]  M. Krause,et al.  Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.

[9]  C. Sudlow,et al.  Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network , 2014, Stroke.

[10]  Z. Rumboldt,et al.  Infarct Patterns, Collaterals and Likely Causative Mechanisms of Stroke in Symptomatic Intracranial Atherosclerosis , 2014, Cerebrovascular Diseases.

[11]  Mark D. Johnson,et al.  Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial , 2014, The Lancet.

[12]  T. Turan,et al.  Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment , 2013, The Lancet Neurology.

[13]  A. Demchuk,et al.  Perfusion MR Predicts Outcome in High-Risk Transient Ischemic Attack/Minor Stroke: A Derivation–Validation Study , 2013, Stroke.

[14]  Manabu Inoue,et al.  MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study , 2012, The Lancet Neurology.

[15]  S. Dey Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis , 2012 .

[16]  T. Turan,et al.  Collaterals dramatically alter stroke risk in intracranial atherosclerosis , 2011, Annals of neurology.

[17]  Geoffrey A. Donnan,et al.  RAPID Automated Patient Selection for Reperfusion Therapy: A Pooled Analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study , 2011, Stroke.

[18]  K. Tan,et al.  Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial , 2010, The Lancet Neurology.

[19]  M. Marks,et al.  Angioplasty for Symptomatic Intracranial Stenosis: Clinical Outcome , 2006, Stroke.

[20]  H. A. Smith,et al.  A standardized method for measuring intracranial arterial stenosis. , 2000, AJNR. American journal of neuroradiology.